Alfresa : Contributing to Regional Healthcare

Non-Financial Strategy

Contributing to Regional Healthcare

To meet regional healthcare needs and help support the realization of the Community Health Care Vision, the Alfresa Group cooperates with medical institutions and makes a Groupwide effort to contribute to the health and medical care of the community.

Signing of an Agreement to Improve the Cancer Screening Rate (Ibaraki Prefecture)

In the fiscal year ended March 31, 2022, Alfresa Corporation and Ibaraki Prefecture entered into a partnership to increase the cancer screening rate within the prefecture. We have undertaken several initiatives to boost this rate among resi- dents. For instance, we have created posters for display at customers' establishments. We have also organized web seminars on cancer awareness to help our employees spread accurate knowledge about the disease. In addition to paid leave, the Company has established a system that allows the use of accumulated leave*1 specifically for cancer treatment (such as hospital visits). Furthermore, the Company has worked to increase participation in cancer screenings through such initiatives as fully or partially subsidizing employee health check-ups and cancer screenings. In recognition of these efforts, in October 2022, the Company received the Award for excellence from Ibaraki Prefecture at the Ibaraki Cancer Forum 2022, an event focused on living with cancer.

*1 A system that allows for the accumulation of up to 40 days of paid leave that would normally have expired and been unusable

diabetic nephropathy. In response to this program, prefectural and municipal medical associations and primary care physicians are collaborating to implement initiatives such as identifying high-risk individuals, encouraging them to seek medical attention, and providing health guidance.

The program will provide six months of self-care guidance for individuals with diabetic nephropathy who are in the pre- dialysis stage, in collaboration with the medical institutions where the participants receive treatment and the local pharmacists at nearby community pharmacies. In implementing the program, we will use the services of M Adhere Inc., which is a subcontractor of Alfresa Corporation. In encouraging participation in the program, we will prioritize recommendations by attending physicians and pharmacists, facilitating support that leads to the development of individualized treatment plans and the implementation of instructions from attending physicians for individual patients.

*2	The Ministry of Health, Labour and Welfare introduced
	this program in an April 20, 2016, press release entitled

"Formulation of a Program to Prevent the Exacerbation of Diabetic Nephropathy."

https://www.mhlw.go.jp/file/04-Houdouhappyou-12401000-Hokenkyoku-­Soumuka/0000121900.pdf (Japanese only)

Stakeholder Relationships and Timing of Guidance

Outsource business

Ibaraki Cancer Forum 2022	Award for Excellence in Promoting Cancer
	Screening

Contracted to Handle Diabetic Nephropathy Exacerbation Prevention

				Kodaira City
	Request cooperation
						Training	and
							support
Kodaira Medical Association	Kodaira Pharmaceutical Association	Introduction
	Sharing of			operational
	consultation results
						Training
Attending physicians		Pharmacists
Develop an		Meet with
individualized		participants to
treatment plan for		remove obstacles
each patient and		that would keep

Recommending participation Role to people in operational

control of the business

M·Adhere Inc.

Diabetes

healthcare advisor

Outside experts

Business (Kodaira City, Tokyo)

Alfresa Corporation has been contracted to handle the national public health insurance business and the diabetic nephropathy

provide them with		them from
written		implementing their	Advice
instructions for	Participants	doctor's instructions
daily life.	(patients)	(motivational
	support).

Registered

dietician

Role Quality

control

exacerbation prevention business in the city of Kodaira, Tokyo. As its population ages, Japan is seeing an increase in the number of diabetes patients and a significant decline in patient quality of life (QOL) due to complications resulting from untreated illnesses, as well as a growing medical and economic burden on society. In response, the Ministry of Health, Labour and Welfare introduced the Diabetic Nephropathy Exacerbation Prevention Program*2 in April 2016 to support efforts at a national level to prevent the exacerbation of

Orientation

Starting

First

Second

Third

Fourth

Fifth

Sixth

of the

month

month

month

month

month

month

month

medication

Meeting

Meeting

Meeting

receipt

Meeting

Meeting

Meeting

(telephone)

(telephone)

(telephone)

Meeting

Upon

Program

Establish behavioral goals, listen, check

explanation,

for residual medication, assess diet,

consent form,

conduct questionnaires, and hold case

questionnaire,

conferences in the course of support

and residual drug check

(optional)

Collaborate with

attending physicians to help patients increase their sense of self-efficacy.

• Desire to confront the disease
• Attitude of striving toward behavioral goals

54 Alfresa Group Integrated Report 2023